DI Staso Silvio, Agnifili Luca, Ciancaglini Marco, Murano Gianluca, Borrelli Enrico, Mastropasqua Leonardo
Department of Life, Health and Environmental Sciences, University of L'Aquila, Ophthalmology Clinic, L'Aquila, Italy.
Ophthalmology Clinic, Department of Medicine and Science of Ageing, University G. D'Annunzio Chieti Pescara, Chieti, Italy.
In Vivo. 2018 Mar-Apr;32(2):437-443. doi: 10.21873/invivo.11259.
The aim of this study was to evaluate the goblet cell density (GCD) of conjunctiva in medically-controlled glaucoma using laser scanning confocal microscopy (LSCM).
Fifty-five glaucomatous patients were enrolled and divided into two groups: Group 1 (27 eyes), controlled with one medication; and group 2 (28 eyes), controlled with two medications. Seventeen patients with dry eye disease (DED) and 17 healthy individuals served as controls. Patients completed the Ocular Surface Disease Index (OSDI) questionnaire and underwent determination of tear film break-up time (BUT), corneal staining, and Schirmer test I. For the GCD assessment, 12 high-quality images were acquired from the upper conjunctival epithelium (superior nasal, superior central, and superior temporal sectors).
Overall, GCD was significantly reduced in both glaucoma groups and those with DED compared to healthy controls (p<0.001), with values markedly lower in group 2 compared to group 1 (p<0.05). GCD was not significantly different between those with DED and group 2. A significant negative correlation was found of GCD with OSDI and with BUT (p<0.001; R=-0.795 and R=-0.756, respectively).
Glaucoma therapy leads to a marked reduction of GCs, especially in the associative regimens. Given the negative correlation with tear film function tests, GCD reduction may play a pivotal role in the pathophysiology of the glaucoma-related disease of the ocular surface.
本研究旨在利用激光扫描共聚焦显微镜(LSCM)评估药物控制的青光眼患者结膜杯状细胞密度(GCD)。
纳入55例青光眼患者并分为两组:第1组(27只眼),使用一种药物控制;第2组(28只眼),使用两种药物控制。17例干眼症(DED)患者和17名健康个体作为对照。患者完成眼表疾病指数(OSDI)问卷,并接受泪膜破裂时间(BUT)测定、角膜染色和Schirmer I试验。为评估GCD,从结膜上皮上部(鼻上、中央上和颞上象限)采集12张高质量图像。
总体而言,与健康对照相比,青光眼组和DED组的GCD均显著降低(p<0.001),第2组的值明显低于第1组(p<0.05)。DED组和第2组之间的GCD无显著差异。发现GCD与OSDI和BUT均呈显著负相关(p<0.001;R分别为-0.795和-0.756)。
青光眼治疗导致杯状细胞显著减少,尤其是在联合用药方案中。鉴于与泪膜功能测试呈负相关,GCD降低可能在青光眼相关眼表疾病的病理生理学中起关键作用。